| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 62135-681-30 | 62135-681 | HUMAN PRESCRIPTION DRUG | Metformin Hydrochloride | Metformin Hydrochloride | TABLET | ORAL | 20220406 | N/A | ANDA | ANDA075972 | Chartwell RX, LLC | METFORMIN HYDROCHLORIDE | 625 mg/1 | 30 TABLET in 1 BOTTLE (62135-681-30) |
| 62135-681-90 | 62135-681 | HUMAN PRESCRIPTION DRUG | Metformin Hydrochloride | Metformin Hydrochloride | TABLET | ORAL | 20220406 | N/A | ANDA | ANDA075972 | Chartwell RX, LLC | METFORMIN HYDROCHLORIDE | 625 mg/1 | 90 TABLET in 1 BOTTLE (62135-681-90) |
| 72336-064-30 | 72336-064 | HUMAN PRESCRIPTION DRUG | Metformin Hydrochloride | Metformin Hydrochloride | TABLET | ORAL | 20220501 | N/A | ANDA | ANDA075972 | Lifsa Drugs, LLC | METFORMIN HYDROCHLORIDE | 625 mg/1 | 30 TABLET in 1 BOTTLE (72336-064-30) |